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Introduction
The p�ys�olo���al f���t�o�s of ��ma� ep��ard�al ad�pose t�ss�e (�AT) are �ot �ell�defi�ed most l�kely �e�a�se t��s strate���ally lo�ated ad�pose t�ss�e depot �s d�ffi��lt to a��ess a�d st�dy, a�d most of t�e ��format�o� a�o�t �t �omes from ��ma�s ��t� severe �ar� d�a� d�sease or �y ��fere��e from a��� mal exper�me�ts (1, 2) . �ypot�et��ally, �AT's f���t�o�s ���l�de l�p�d stora�e for myo�ard�al e�er�y �se, �oro�ary artery me��a���al ��ffer��� a�a��st arter�al �ave tors�o�, �oro�ary artery vasomot�o� a�d remodel���, prote�� t�o� of t�e �ard�a� a�d �oro�ary a�� to�om�� �erve s�pply, a�d se�ret�o� of ad�pok��es, a �olle�t�ve defi��t�o� for ���te ad�pose t�ss�e�der�ved �or� mo�es, �ro�t� fa�tors, �oa��lat�o� med�ators, a�d pro�a�d a�t����flam� matory �ytok��es a�d ��emok��es (1�3).
The �ormo�es, ad�po�e�t�� a�d lept��, a�d t�e �ytok��es, t�mor �e�� ros�s fa�tor�alp�a (T�F�α), mo �o �yte ��emoattra�ta�t prote���1 (MCP�1), ��terle�k��(�L)�1β a�d �L�6 are se� �reted in vitro �y expla�ts of �AT o�ta��ed from pat�e�ts ��der�o��� �oro�ary artery �ypass �raft for severe
Abstract
Human epicardial adipose tissue expresses and secretes in vitro hormones and inflammatory cytokines and chemokines collectively termed adipokines. We hypothesized that human epicardial fat did not secrete adipokines into coronary blood under basal conditions in vivo. Adiponectin, leptin, resistin, tumor necrosis factor-α, monocyte chemoattractant protein-1, active plasminogen-activator inhibitor-1, interleukin-1β,-6,-8 and vascular endothelial growth factor were measured simultaneously in femoral arterial (a surrogate for coronary arterial) blood and coronary sinus venous blood from eleven patients, mostly young non-obese women, without known heart disease undergoing cardiac catheterisation for radioablation of supraventricular tachycardia. Mean adipokine concentrations were not significantly different in both vessels. In contrast, free fatty acid levels were significantly higher in femoral arterial than coronary sinus blood in keeping with net uptake of free fatty acids by the myocardium. Femoral artery levels of monocyte chemoattractant protein-1, active plasminogen activator inhibitor-1, leptin and resistin showed positive correlations with BMI in descending order of significance but adiponectin showed no relationship. Values for the other adipokines were below the assay detection limit in several patients negating the use of regression analysis. As opposed to their secretion in vitro, the adipokines described above are not secreted into coronary blood by human epicardial adipose tissue under near-normal basal conditions in vivo and are more likely released into the interstitium of the myocardium and coronary vessels to function as local paracrine regulators. �oro�ary at�eros�lerot�� d�sease (CAD) or �eart valve repla�e� me�ts ��t�o�t CAD (4, 5) . mR�As for t�ese prote��s a�d re� s�st��, �L�8, a�t�ve plasm��o�e��a�t�vator ������tor�1 (aPA��1), a�d vas��lar e�dot�el�al �ro�t� fa�tor (V��F) are expressed �y �AT sampled ��traoperat�vely (4�7). By defi��t�o�, t�e des���a� t�o� of ep��ard�al fat as a� e�do�r��e t�ss�e req��res t�at lept�� a�d ad�po�e�t�� or ot�er ad�pok��es are se�reted from �AT ��to t�e �oro�ary ve�o�s effl�e�t. The res�lts of exper�me�ts test��� ad�po�e�t�� �a�dl��� a�ross t�e ��ma� �oro�ary vas��lar �ed �ave �ee� �o�trovers�al. �� s���e�ts ��t�o�t a���o�rap��� CAD or type 2 d�a�etes mell�t�s (T2DM), t�ere �as a small (~5%) s����fi�a�t ���rease �� �oro�ary ve�o�s s���s (CVS) �ompared to �oro�ary artery (CA) ad�po�e�t�� s���est��� release of ad�� po�e�t�� from �AT (8) . �� a�ot�er report (9) , aort�� root ad�� po�e�t�� levels �ere s����fi�a�tly ����er (~10�15%) t�a� CVS ad�po�e�t�� levels �� �o��d�a�et�� pat�e�ts ��t�o�t a�d ��t� CAD s���est��� �ard�a� �ptake of t��s ad�pok��e (9) . Se�ret�o� of t�e ot�er ad�pok��es ��to ��ma� �oro�ary �lood �as �ot �ee� determ��ed.
The p�rpose of t��s st�dy �as to meas�re s�m�lta�eo�s femo� ral artery (FA) a�d CVS �lood �o��e�trat�o�s of ad�po�e�t��, lept��, res�st��, aPA��1, MCP�1, T�F�α, �L�1β,�6,�8, V��F, ��� s�l��, �l��ose, a�d free fatty a��ds (FFA) �� pat�e�ts ��der�o��� �ard�a� �at�eter�zat�o� to a�late s�prave�tr���lar ta��y�ard�a (10) . We �ypot�es�zed t�at ad�pok��e levels �o�ld �ot �e ����er �� CVS t�a� �� FA �lood �� t��s �ro�p of pat�e�ts. The rat�o�ale for ���l�d��� ��s�l��, �l��ose a�d FFA �as to �se t�em as �om� parators of �ormo�e a�d meta�ol�� s��strate meta�ol�sm �y t�e �eart d�r��� t�e exper�me�t.
Subjects and methods
Patients �a�� pat�e�t �ad a� esta�l�s�ed d�a��os�s of atr�ove�tr���lar �odal re�e�try s�prave�tr���lar ta��y�ard�a (SVT) for ����� slo� pat��ay rad�ofreq�e��y �at�eter a�lat�o� (10) �as deemed �e�essary �y t�e �ard�olo��st (�J). �x�l�s�o� �r�ter�a �ere a�e 16 or ��der; a left ve�tr���lar e�e�t�o� fra�t�o� eq�al to or less t�a� 50%; ev�de��e of �oro�ary at�eros�leros�s, �ard�omyopa� t�y, ��ro��� valv�lar �eart d�sease a�d �o��est�ve �ard�a� fa�l� �re; past or prese�t ���arette smok���; t�e prese��e of a��te or ��ro��� p�lmo�ary, �epat��, re�al, �olla�e��vas��lar, �astro��� test��al or �e�rom�s��lar d�sease a�d T2DM, defi�ed as a fast� ��� �lood �l��ose of 126 or more (11) . Th�s st�dy �as approved �y t�e lo�al ��st�t�t�o�al Rev�e� Board. All pat�e�ts ��volved �ave t�e�r ��formed �o�se�t.
Sampling proceedure
�� t�e mor���� after a� over����t fast, pat�e�ts �ere ��ve� e�� dotra��eal �e�eral a�est�es�a �� t�e �ard�a� �at�eter�zat�o� la�oratory.�le�tro�ard�o�rap��� a�d �emody�am�� mo��tor��� �ere esta�l�s�ed. La�tated R���ers sol�t�o� ��t�o�t �l��ose �as ��f�sed v�a a per�p�eral ve��. Cat�eters �ere ��serted ��to a FA for �emody�am�� mo��tor��� a�d ��to t�e CVS. The pos�t�o� of t�e �at�eter t�p �� t�e CVS �as �o�firmed fl�oros�op��ally ��st �efore ��t�dra���� �lood samples to e�s�re �o m�x��� of r���t atr�al ��t� CVS �lood. U�der sta�le �emody�am�� �o�d�t�o�s, t�e first 7�10 ml a�d 5 ml of �lood dra�� s�m�lta�eo�sly from t�e FA a�d CVS �at�eters respe�t�vely �ere d�s�arded to avo�d �o�tam��at�o� a�d 10 ml �ere dra�� from t�e FA a�d t�e CVS over ~30 se� 10 a�d 5 m���tes �efore t�e start of atr�al a�d ve�� tr���lar pro�rammed ele�tr��al st�m�lat�o�. The samples �ere �mmed�ately tra�sferred ��to �epar���sed t��es �� ��e. Plasma �as separated at 4C a�d samples stored at -80C ��t�l assayed.
Assays �l��ose �as meas�red �y a�toa�alyser �� t�e �osp�tal la�o� ratory. FFA �ere meas�red �y Q�est D�a��ost��s, ����ols ��� st�t�te, Sa� J�a� Cap�stra�o, CA, �s��� a� in vitro e�zymat�� �olor�metr�� met�od t�at re�o���zes a var�ety of FFA ���l�d� ��� palm�t��, stear��, ara���do���, ole��, palm�tole��, l��ole��� a�d l��ole��. Total ad�po�e�t��, res�st��, T�F�α, MCP�1, �L� 1β,�6,�8, aPA��1, a�d V��F �ere meas�red �y B�os��e��e D�� v�s�o� La�orator�es, M�ll�pore Corporat�o�, St C�arles, M� �s��� L��C�plex �ell plate �mm��oassays ��t� spe��fi� a�� t��ody��mmo��l�sed fl�ores�e�t�la�elled m��rosp�ere �eads. Assay se�s�t�v�ty (M��DC) �as 145 p�/ml for ad�po�e�t��, 6.7 p�/ml for res�st�� a�d 1.3 p�/ml for aPA��1, a�d per �e�t ��tra� assay a�d ��ter�assay var�at�o� (% �v) �ere respe�t�vely 3.4 a�d 13.7 for ad�po�e�t��, 2.2 a�d 17.2 for res�st��, a�d 4.1 a�d 9.9 for aPA��1. For ea�� of T�F�α, MCP�1, �L�1β,�6,�8 a�d V��F assays, M�� DC �as 3.2 p�/ml, ��tra�assay % �v �as 5.8�10.5% a�d ��ter�assay % �v �as 7.0�15.9. ��s�l�� a�d lept�� �ere meas�red �y do��le a�t��ody rad�o�mm��assays. For ��s�l��, M�� DC �as 2μU/ml, ��tra�assay % �v 3.2 a�d ��ter�assay % �v 3.9. For lept��, M��DC �as 0.5 ��/ml, ��tra�assay % �v 5.0 a�d ��ter�assay % �v 4.5. Fra�t�o�ated plasma �ate��olam��es �ere meas�red �y ���� press�re l�q��d ��romato�rap�y ��t� ele�tro��em��al dete�t�o� (�soter�x La�orator�es, B�rl���to�, �C).
Statistical Analysis
FA a�d CVS �o��e�trat�o�s of �l��ose, FFA, ��s�l�� a�d ea�� ad�pok��e dra�� at 10 a�d at 5 m���tes �ere avera�ed. For ea�� s��sta��e, d�ffere��es �� FA a�d CVS �o��e�trat�o�s �ere a�a� lysed �s��� a 2�ta�led St�de�t's t test. A p val�e of <0.05 �as �o�� s�dered to ��d��ate a s����fi�a�t d�ffere��e.
Results

Patients
The �pper part of Ta�le 1 s�o�s t�e order pat�e�ts �ere re�r��t� ed to t�e st�dy. �� �ompl�a��e ��t� prespe��fied sele�t�o� �r�� ter�a a�d �y ��a��e, all pat�e�ts ex�ept ��m�er 4 �ere female. Pat�e�t 1 (58 yr) a�d 8 (79 yr) �ere older, �e���ed more, �ad �yperte�s�o� �o�trolled ��t� o�e or 2 �lood press�re dr��s a�d �ad �ormal ��est xrays, �ormal e��o�ard�o�rams (�C��), �or� mal e�e�t�o� fra�t�o�s (�F) of 60% a�d �ormal �oro�ary a���� o�rams.The rema����� 9 yo���er �o��o�ese pat�e�ts �ad �or� mal ��est xrays, �ormal �C�� a�d �ormal �F (58�65%) a�d t�e performa��e of �oro�ary a���o�rap�y �� t�em �as deemed �ot to �e �l����ally �e�essary. Pat�e�ts 1, 5 a�d 11 �ere tak��� estro�e���o�ta����� med��at�o�s.
Plasma glucose, FFA, insulin and adipokines in FA and CVS blood 
As a� ��d��ator of sympat�et�� adre�omed�llary a�t�vat�o� at t�e t�me of �lood sampl��� d�r��� t�e pro�ed�re, FA ep��e� p�r��e a�d �or�ep��ep�r��e �o��e�trat�o�s �� 8 pat�e�ts (data �ot s�o��) �ere �� t�e �ormal ra��e (respe�t�vely <100 p�/ml a�d <400 p�/ml) �o�firm��� �o �ate��olam��e release ��der t�ese exper�me�tal �o�d�t�o�s. (16) . �� t��s s�t�� at�o�, t�ere �o�ld �e �o st�m�l�s for ma�rop�a�e ��filtrat�o� ��to ad�pose t�ss�e med�ated �y ad�po�yte �ypertrop�y from �e���t �a�� a�d �o �e�erat�o� of ��flammatory �ytok��es �y ad�po�ytes a�d ��flammatory �ells �� t�e stromal�vas��lar fra�� t�o�s of �AT (2) . �t �s of ��terest t�at �e d�d �ot o�serve a�y step��p �� ad�pok��e �rad�e�ts �� 3 pat�e�ts ��t� sta�e ��� o�es� �ty ��t t�e s����fi�a��e of t��s fi�d��� rema��s ���lear pe�d��� f�rt�er st�d�es. Se�o�dly, at a�topsy, ma�rop�a�e de�s�ty �s lo� �� �AT s�rro��d��� �ormal �oro�ary arter�es (17) .We ��fer t�at t��s �as also t�e �ase �� o�r pat�e�ts ��o �ere ass�med �ot to �ave CAD �y v�rt�e of a�se��e of r�sk fa�tors s��� as a�e, smok� ���, �yperte�s�o� or d�a�etes mell�t�s or �y �ormal �oro�ary a���o�rams �� sele�ted �ases. By �o�trast, �� pat�e�ts ��t� se� vere CAD, ��flammatory ad�pok��es are expressed a�d se�reted �� �reater amo��ts from �AT (4,5,7) a�d t�erefore t�e pote�t�al ex�sts t�at o�e or more ad�pok��es m���t �e released from �AT ��to �oro�ary �lood ��der pat�op�ys�olo���al ��r��msta��es. Th�s �ss�e req��res f�rt�er st�dy. Re�ress�o� a�alys�s a�d �orrelat�o� of system�� �lood ad�� pok��es ��t� BM� �as �ot t�e pr�mary fo��s of t��s ��vest��a� t�o�. Desp�te t��s, �e �oted s����fi�a�t pos�t�ve �orrelat�o�s �et�ee� BM� a�d FA �o��e�trat�o�s of lept�� a�d aPA��1 as prev�o�sly reported (18, 19) , a�d �et�ee� BM� a�d res�st��. The pos�t�ve �orrelat�o� �e fo��d �et�ee� BM� (mea� 27.4 k�/m 2 ) a�d MCP�1 �o�trasts ��t� �o �orrelat�o� �� a st�dy �� ����� per�p�eral ve�� �lood �as o�ta��ed from o�ese (mea� BM� 43.5) ot�er��se �ealt�y �ome� (20) . The d�ffere��e �o�ld �e d�e to d�ffere�t �ody �e���ts, sele�t�o� �r�ter�a a�d ��m�er of s���e�ts. Total ad�po�e�t�� d�d �ot s�o� t�e expe�ted ��verse relat�o�s��p ��t� BM� (21), pro�a�ly �e�a�se t�e ��m�ers �ere too small. �� several pat�e�ts, val�es for t�e rema����� ad�pok� ��es �ere �elo� t�e assay dete�t�o� l�m�t l�ke��se red����� t�e ��m�ers for a�alys�s a�d l�m�t��� a�y defi��t�ve �o��l�s�o�s.
Mea� FFA �ere s����fi�a�tly lo�er (14.0%) �� t�e CVS t�a� t�e FA. Th�s d�ffere��e �s a� ��derest�mate of myo�ard�al FFA extra�t�o� �e�a�se rad�oa�t�ve tra�er�la�elled FFA ��f�s�o�s s�o� t�at ���le FFA are �e��� take� �p, e�do�e�o�s FFA are s�m�lta�eo�sly released from �AT �y l�polys�s ����� ra�ses t�e effl�e�t FFA �o��e�trat�o� (22, 23) .Co��l�s�o�s a�o�t �l��ose fl�x a�ross t�e �eart �� t�ese exper�me�ts �a��ot �e made ��t�� o�t t�e �se of rad�oa�t�ve �l��ose tra�ers (24) .The �arely per�ep� t��le ����er �l��ose �o��e�trat�o� �� FA t�a� CS �mpl�es �l��ose t�r�over at m��� lo�er rates �ompared to FFA, �� keep��� ��t� t�e �ormal myo�ard�al prefere��e for FFA over �l��ose as e�� 
Discussion
�� a �ro�p of ot�er��se �ealt�y pat�e�ts ��t� SVT a�d �o ot�er �ard�a� a��ormal�t�es, �e fo��d �o s����fi�a�t d�ffere��es �e� t�ee� fast��� �asal �o��e�trat�o�s of ad�po�e�t��, lept��, res�s� t��, aPA��1, MCP�1, T�F�α, �L�1β,�6,�8 a�d V��F �� FA �om� pared to CVS �lood. ��ve� t�e 7.1% ����er aPA��1 val�es �� CVS t�a� FA (p=0.07), t�e ��m�er of pat�e�ts exam��ed may �ot �ave �ee� s�ffi��e�t to ex�l�de aPA��1 release. W�t� t��s pro� v�s�o�, t�e data s�pports t�e �ypot�es�s t�at t�ese prote��s are �ot se�reted ��to t�e �oro�ary ve�� effl�e�t �� relat�vely �ealt�y people a�d t�at t�e�r p�ys�olo���al f���t�o� �� �AT �s pro�a�ly �ot e�do�r��e ��t para�r��e ��ere�y t�ey are se�reted from �AT d�re�tly ��to t�e �losely apposed myo�ard��m a�d �oro�ary vessels. The res�lts also s���est t�at t�e �o�tr���t�o� of �AT to overall ad�pok��e t�r�over �ormally �s �e�l����le. Th�s does �ot ex�l�de t�e poss���l�ty t�at ot�er �ormo�es released from ���te ad�pose t�ss�e depots ��to system�� �lood t�at �ere �ot meas� �red �� t��s st�dy s��� as ret��ol����d��� prote�� 4 (12), a���� ote�s�� �� (13) a�d ome�t�� (14) m���t �e se�reted from �AT �� e�do�r��e fas��o�. The la�k of a� ���rease �� CVS ad�pok��es relat�ve to FA ad�� pok��es o�served �� t��s st�dy m���t �e d�e to t�e fa�t t�at �AT �as �ot �� a state of ��ro��� ��flammat�o� ����� �s ��ara�ter� �zed �y ���reased express�o� of all t�e ad�pok��es meas�red ex� �ept for ad�po�e�t�� (2,3) a�d �erve �ro�t� fa�tor a�d �ra��� er�y s��strate �� t�e �asal fast��� state (25, 26) . D�ffere�t res�lts m���t �e o�served ��der �o��fast��� or �yper�ly�em�� a�d/or �yper��s�l��em�� ��r��msta��es (24) or ��der �o�d�t�o�s of ��� �reased �ard�a� �ork a�d oxy�e� �o�s�mpt�o� (25) .There �as �o o�served �ptake of ��s�l�� eve� t�o��� t�e �eart �as ��s�l�� re�eptors (27) ����� med�ate ��s�l�� removal from ��r��lat��� �lood. ��r st�dy �as several met�odolo���al l�m�tat�o�s. F�rstly, �e ass�med t�at �o��e�trat�o�s of ad�pok��es �� t�e FA a�d t�e CVA are t�e same. �t���al �o�stra��ts d�d �ot perm�t �s to pla�e a �at�eter �� t�e CVA or t�e aort�� root �ext to t�e CA for �lood sampl���. �o�ever, sampl��� of FA �lood ��stead of CVA �lood �as �ee� �sed �� ��ma� �eart meta�ol�sm exper�me�ts d�r��� �ard�a� �at�eter�zat�o� (25) . ��ma� aort�� root a�d per�p�eral ve�� ad�po�e�t�� �o��e�trat�o�s are �ot s����fi�a�tly d�ffere�t (28) so t�at sampl��� t�e FA �loser "�pstream" to t�e �oro�ary or�fi�e �o�ld more l�kely refle�t CVA �lood t�a� �o�ld a pe� r�p�eral ve�� sample. These l��es of ev�de��e s�pport FA as a s�rro�ate for CVA �lood. Se�o�dly, �e ass�med t�at �lood flo� a�ross t�e �oro�ary vas��lar �ed rema��ed �o�sta�t d�r��� sampl��� �e�a�se d�re�t meas�reme�ts of �oro�ary flo� �ere �ot made. Th�s �as l�kely to �e t�e �ase �e�a�se d�r��� t�e pro� �ed�re, �e�eral �emody�am�� parameters �ere sta�le a�d t�e rate of �lood ��t�dra�al from t�e CVS �as slo� (24) . Th�rdly, meas�reme�ts of arter�ove�o�s d�ffere��es a�ross t�e �oro�ary vas��lar �ed are s�mple represe�tat�o�s of �et fl�x a�d �a��ot a���rately q�a�t�tate release or �ptake of ea�� s��sta��e. For example, �e �a��ot ex�l�de t�e poss���l�ty t�at ad�po�e�t�� a�d lept�� may �e take� �p �y t�e myo�ard��m from t�e �oro�ary ��fl�x at t�e same t�me as t�ey are released ��to t�e effl�x from �AT, res�lt��� �� �o �et ��a��e �� t�e�r tra�smyo�ard�al val�es. Lastly, �AT t���k�ess or vol�mes �ere �ot meas�red ��t t��s s�o�ld �ot detra�t from t�e pr����ple fi�d���s of t�e st�dy. �� t�e �o�trary, �f t�e effl�e�t �o��e�trat�o�s of o�e or more �oro� �ary ad�pok��es �ad �ee� ����er, �t �o�ld �ave �ee� esse�t�al to q�a�t�tate t�e amo��t of �AT to expla�� t�e o�t�vers�s��� d�ffere��es �et�ee� t�em.
Conclusion
We �ere ��a�le to demo�strate a�y d�ffere��es �et�ee� FA a�d CVS levels of ad�po�e�t��, lept��, res�st��, aPA��1, MCP�1, T�F�α, �L�1β,�6,�8 a�d V��F �� �lood travers��� t�e �earts of s���e�ts ��der �asal �o�d�t�o�s. �� t��s �o�text, �AT �s �ot a� e�do�r��e or�a�. Ad�pok��es expressed �y ��ma� �AT are more l�kely released ��to t�e ��terst�t��m of t�e myo�ard��m a�d �oro�ary vessels to a�t as lo�al para�r��e re��lators in vivo.
